154 related articles for article (PubMed ID: 18700858)
1. N-acetyl-beta-D-glucosaminidase index as an early biomarker for chronic kidney disease in cats with hyperthyroidism.
Lapointe C; Bélanger MC; Dunn M; Moreau M; Bédard C
J Vet Intern Med; 2008; 22(5):1103-10. PubMed ID: 18700858
[TBL] [Abstract][Full Text] [Related]
2. Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease.
Williams TL; Dillon H; Elliott J; Syme HM; Archer J
J Vet Intern Med; 2016 Jul; 30(4):1083-9. PubMed ID: 27155206
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Serum Symmetric Dimethylarginine Concentration as a Marker for Masked Chronic Kidney Disease in Cats With Hyperthyroidism.
Peterson ME; Varela FV; Rishniw M; Polzin DJ
J Vet Intern Med; 2018 Jan; 32(1):295-304. PubMed ID: 29377360
[TBL] [Abstract][Full Text] [Related]
4. Urinary iodide concentration in hyperthyroid cats.
Wakeling J; Elliott J; Petrie A; Brodbelt D; Syme HM
Am J Vet Res; 2009 Jun; 70(6):741-9. PubMed ID: 19496664
[TBL] [Abstract][Full Text] [Related]
5. Symmetric dimethylarginine in hyperthyroid cats before and after treatment with radioactive iodine.
DeMonaco SM; Panciera DL; Morre WA; Conway T; Werre S
J Feline Med Surg; 2020 Jun; 22(6):531-538. PubMed ID: 31290362
[TBL] [Abstract][Full Text] [Related]
6. Assessment of urinary N-acetyl-beta-D-glucosaminidase activity in geriatric cats with variable plasma creatinine concentrations with and without azotemia.
Jepson RE; Vallance C; Syme HM; Elliott J
Am J Vet Res; 2010 Feb; 71(2):241-7. PubMed ID: 20113234
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of predictors of the development of azotemia in cats.
Jepson RE; Brodbelt D; Vallance C; Syme HM; Elliott J
J Vet Intern Med; 2009; 23(4):806-13. PubMed ID: 19566846
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term follow-up of glomerular and tubular renal markers of kidney function in hyperthyroid cats after treatment with radioiodine.
van Hoek I; Lefebvre HP; Peremans K; Meyer E; Croubels S; Vandermeulen E; Kooistra H; Saunders JH; Binst D; Daminet S
Domest Anim Endocrinol; 2009 Jan; 36(1):45-56. PubMed ID: 19010632
[TBL] [Abstract][Full Text] [Related]
9. Association of iatrogenic hypothyroidism with azotemia and reduced survival time in cats treated for hyperthyroidism.
Williams TL; Elliott J; Syme HM
J Vet Intern Med; 2010; 24(5):1086-92. PubMed ID: 20695989
[TBL] [Abstract][Full Text] [Related]
10. Urine concentrating ability in cats with hyperthyroidism: Influence of radioiodine treatment, masked azotemia, and iatrogenic hypothyroidism.
Peterson ME; Rishniw M
J Vet Intern Med; 2023; 37(6):2039-2051. PubMed ID: 37668163
[TBL] [Abstract][Full Text] [Related]
11. Effect of treatment of hyperthyroidism on renal function in cats.
DiBartola SP; Broome MR; Stein BS; Nixon M
J Am Vet Med Assoc; 1996 Mar; 208(6):875-8. PubMed ID: 8617644
[TBL] [Abstract][Full Text] [Related]
12. Association between urinary vascular endothelial growth factor excretion and chronic kidney disease in hyperthyroid cats.
Williams TL; Elliott J; Syme HM
Res Vet Sci; 2014 Jun; 96(3):436-41. PubMed ID: 24656748
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of hyperthyroidism in cats with mild chronic kidney disease.
Wakeling J; Moore K; Elliott J; Syme H
J Small Anim Pract; 2008 Jun; 49(6):287-94. PubMed ID: 18422499
[TBL] [Abstract][Full Text] [Related]
14. Survival and the development of azotemia after treatment of hyperthyroid cats.
Williams TL; Peak KJ; Brodbelt D; Elliott J; Syme HM
J Vet Intern Med; 2010; 24(4):863-9. PubMed ID: 20649748
[TBL] [Abstract][Full Text] [Related]
15. Assessment of symmetric dimethylarginine as a biomarker of renal function in hyperthyroid cats treated with radioiodine.
Buresova E; Stock E; Paepe D; Stammeleer L; Vandermeulen E; Smets P; Duchateau L; Lefebvre HP; Daminet S
J Vet Intern Med; 2019 Mar; 33(2):516-522. PubMed ID: 30632628
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant status in hyperthyroid cats before and after radioiodine treatment.
Branter E; Drescher N; Padilla M; Trepanier LA
J Vet Intern Med; 2012; 26(3):582-8. PubMed ID: 22428726
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease.
Chakrabarti S; Syme HM; Elliott J
J Vet Intern Med; 2012; 26(2):275-81. PubMed ID: 22269057
[TBL] [Abstract][Full Text] [Related]
18. Effects of methimazole on renal function in cats with hyperthyroidism.
Becker TJ; Graves TK; Kruger JM; Braselton WE; Nachreiner RF
J Am Anim Hosp Assoc; 2000; 36(3):215-23. PubMed ID: 10825092
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23 (FGF-23) concentrations in cats with early nonazotemic chronic kidney disease (CKD) and in healthy geriatric cats.
Finch NC; Geddes RF; Syme HM; Elliott J
J Vet Intern Med; 2013; 27(2):227-33. PubMed ID: 23363336
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of N-acetyl-beta-D-glucosaminidase and its isoenzymes in cats with urinary disease.
Sato R; Soeta S; Syuto B; Yamagishi N; Sato J; Naito Y
J Vet Med Sci; 2002 Apr; 64(4):367-71. PubMed ID: 12014584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
